Abstract

Objectives: POLE exonuclease domain mutations have previously been described to occur in the tumors of endometrial cancer (EC) patients, and result in the inability to repair mismatched bases during DNA replication. The prognostic impact of these mutations is controversial. We sought to investigate the prevalence of POLE mutation tumor status and its prognostic significance on survival and recurrence outcomes in women with high grade endometrioid EC.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call